Discovery of potential biomarkers for human atherosclerotic abdominal aortic aneurysm through untargeted metabolomics and transcriptomics
- Author:
JI LEI
1
;
CHEN SILIANG
;
GU GUANGCHAO
;
WANG WEI
;
REN JINRUI
;
XU FANG
;
LI FANGDA
;
WU JIANQIANG
;
YANG DAN
;
ZHENG YUEHONG
Author Information
1. Department of Vascular Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China
- Keywords:
Abdominal aortic aneurysm (AAA);
Atherosclerosis (AS);
Untargeted metabolomics;
Transcriptomics
- From:
Journal of Zhejiang University. Science. B
2021;22(9):733-745
- CountryChina
- Language:Chinese
-
Abstract:
Abdominal aortic aneurysm (AAA) and atherosclerosis (AS) have considerable similarities in clinical risk factors and molecular pathogenesis. The aim of our study was to investigate the differences between AAA and AS from the perspective of metabolomics, and to explore the potential mechanisms of differential metabolites via integration analysis with transcriptomics. Plasma samples from 32 AAA and 32 AS patients were applied to characterize the metabolite profiles using untargeted liquid chromatography-mass spectrometry (LC-MS). A total of 18 remarkably different metabolites were identified, and a combination of seven metabolites could potentially serve as a biomarker to distinguish AAA and AS, with an area under the curve (AUC) of 0.93. Subsequently, we analyzed both the metabolomics and transcriptomics data and found that seven metabolites, especially 2'-deoxy-D-ribose (2dDR), were significantly correlated with differentially expressed genes. In conclusion, our study presents a comprehensive landscape of plasma metabolites in AAA and AS patients, and provides a research direction for pathogenetic mechanisms in atherosclerotic AAA.
